Group B Streptococcus vaccination in pregnancy: Moving toward a global maternal immunization program

Flor M. Munoz, Patricia Ferrieri

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Abstract

A group B streptococcus vaccine for pregnant women would add to the currently available vaccines given during pregnancy to protect mothers and their infants against serious and potentially lethal diseases, including tetanus, influenza, pertussis and meningococcal infection. Implementation of the administration of these high priority vaccines during routine prenatal care would result in a maternal immunization program with the potential to have a positive impact in public health globally, by reducing maternal and neonatal morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)D46-D51
JournalVaccine
Volume31
Issue numberS4
DOIs
StatePublished - Aug 28 2013

Keywords

  • Global program
  • Group B streptococcus
  • Maternal immunization
  • Neonates
  • Pregnancy
  • Vaccine

Fingerprint

Dive into the research topics of 'Group B Streptococcus vaccination in pregnancy: Moving toward a global maternal immunization program'. Together they form a unique fingerprint.

Cite this